BMC’s Yawkey building doors are now closed as an entrance as part of our ongoing efforts to enhance our campus and provide you with the best clinical care.

All patients and visitors on our main campus must enter our hospital via Shapiro, Menino, or Moakley buildings, where they will be greeted by team members at a new centralized check-in desk before continuing to the hospital. We are excited to welcome you and appreciate your patience as we improve our facilities.


Andrew A. Wilson MD, is a board-certified pulmonologist at Boston Medical Center (BMC) and an expert in caring for patients with Alpha-1 antitrypsin deficiency (AATD), the most common heritable cause of emphysema. Dr. Wilson is also an associate professor of Pulmonary, Allergy, Sleep & Critical Care Medicine and a primary mentor of graduate students at Boston University Chobanian & Avedisian School of Medicine. His research focuses on advancing the understanding of and treatment for AATD and chronic obstructive pulmonary disease (COPD). Dr. Wilson is the director of the Alpha-1 Center as well as a member of Boston University’s Pulmonary Center, Center for Regenerative Medicine and Evans Center for Interdisciplinary Biomedical Research.

  • Departments

  • Specialties

    Alpha-1 antitrypsin deficiency (AATD), chronic obstructive pulmonary disease (COPD)

  • Administrative Title

    Associate Professor of Pulmonary, Allergy, Sleep & Critical Care Medicine, Boston University Chobanian and Avedisian School of Medicine

  • Residency

    Internal Medicine, University of Texas Southwestern Medical Center, 1999-2002
  • Education

    University of Texas Southwestern Medical School, 1999
  • Board Certifications

    Pulmonary Disease and Critical Care Medicine, American Board of Internal Medicine